WADA invites researchers, with expertise in the field of hematology, to apply for funding to undertake research projects aimed at delivering an anti-doping method that detects autologous blood transfusion (ABT).
At a minimum, the method should:
- be applicable for blood and/or urine;
- be sensitive enough to detect ABT in a proportion of less than 150 mL (or 4%) of transfused, refrigerated or frozen, red blood cells (RBCs) with a window of detection of at least 24/36 hours;
- have a degree of specificity of 99.99% or above; and
- be transferrable to WADA-accredited laboratories for routine anti-doping testing.
The deadline for proposal submission is 31 January 2016.
More information about the research topic, funding and timelines can be found in the Call for Research Proposals document.